Evidence map›Paper›PMID 29106061›Full record

ArticleArthritis & rheumatology (Hoboken, N.J.)2017

2017 European League Against Rheumatism/American College of Rheumatology Classification Criteria for Adult and Juvenile Idiopathic Inflammatory Myopathies and Their Major Subgroups.

Ingrid E Lundberg, Anna Tjärnlund, Matteo Bottai, Victoria P Werth, Clarissa Pilkington, Marianne de Visser, Lars Alfredsson, Anthony A Amato, Richard J Barohn, Matthew H Liang and 28 more

Erratum issued Registry-linked trialAbstract read
In one paragraph

Article in Arthritis & rheumatology (Hoboken, N.J.), 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. It is linked to trial NCT04486261 (High-intensity Strength Training in Patients With Idiopathic Inflammatory Myopathies), which is not on this map. Cited by 320 papers, 10 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
320citing papers in PubMed, 10 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT04486261 nacompletednot on this mapstarted 2021, after this paper: background citation

High-intensity Strength Training in Patients With Idiopathic Inflammatory Myopathies: Changes in Quality of Life, Muscle Strength, Function and Myocellular Parameters

TypeinterventionalSponsorRigshospitalet, DenmarkRan2021 to 2023Enrolled34ConditionsMyositis, Dermatomyositis, Polymyositis, Immune-Mediated Necrotizing MyopathyArmsHigh-intensity strength training
3 · Its place in the literature

Who cites it

320 citing papers in PubMed, 10 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Pooled it
  7. Pooled it
  8. Pooled it
  9. Pooled it
  10. Pooled it
  11. Trial
  12. Trial
  13. Trial
  14. Trial
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Observational

260 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

38 authors.

Ingrid E LundbergKarolinska University Hospital and Karolinska Institutet, Stockholm, Sweden.
Anna TjärnlundKarolinska University Hospital and Karolinska Institutet, Stockholm, Sweden.
Matteo BottaiKarolinska Institutet, Stockholm, Sweden.
Victoria P WerthPhiladelphia VA Medical Center and Hospital of the University of Pennsylvania, Philadelphia.
Clarissa PilkingtonGreat Ormond Street Hospital for Children NHS Trust, London, UK.
Marianne de VisserAcademic Medical Centre, Amsterdam, The Netherlands.
Lars AlfredssonKarolinska Institutet, Stockholm, Sweden.
Anthony A AmatoBrigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts.
Richard J BarohnUniversity of Kansas Medical Center, Kansas City.
Matthew H LiangBrigham and Women's Hospital and Boston VA Healthcare, Boston, Massachusetts.
Jasvinder A SinghMayo Clinic College of Medicine, Rochester, Minnesota, and University of Alabama and Birmingham VA Medical Center, Birmingham, Alabama.
Rohit AggarwalUniversity of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania.
Snjolaug ArnardottirKarolinska Institutet, Stockholm, Sweden.
Hector ChinoyCentral Manchester University Hospitals NHS Foundation Trust, University of Manchester, Manchester, UK.
Robert G CooperUniversity of Liverpool, Liverpool, UK.
Katalin DankóUniversity of Debrecen, Debrecen, Hungary.
Mazen M DimachkieUniversity of Kansas Medical Center, Kansas City.
Brian M FeldmanUniversity of Toronto and The Hospital for Sick Children, Toronto, Ontario, Canada.
Ignacio Garcia-De La TorreHospital General de Occidente, Secretaría de Salud and University of Guadalajara, Guadalajara, Mexico.
Patrick GordonKing's College Hospital NHS Foundation Trust, London, UK.
Taichi HayashiUniversity of Tsukuba, Tsukuba, Japan.
James D KatzNational Institute of Arthritis and Musculoskeletal and Skin Diseases, NIH, Bethesda, Maryland.
Hitoshi KohsakaTokyo Medical and Dental University, Tokyo, Japan.
Peter A LachenbruchOregon State University, Corvallis.
Bianca A LangIWK Health Centre and Dalhousie University, Halifax, Nova Scotia, Canada.
Yuhui LiPeople's Hospital of Beijing University, Beijing, China.
Chester V OddisUniversity of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania.
Marzena OlesinskaNational Institute of Geriatrics, Rheumatology and Rehabilitation, Warsaw, Poland.
Ann M ReedDuke University, Durham, North Carolina.
Lidia Rutkowska-SakInstitute of Rheumatology, Warsaw, Poland.
Helga SannerOslo University Hospital-Rikshospitalet, Oslo, Norway.
Albert Selva-O'CallaghanVall d'Hebron General Hospital, Barcelona, Spain.
Yeong-Wook SongSeoul National University College of Medicine, Seoul, Republic of Korea.
Jiri VencovskyCharles University, Prague, Czech Republic.
Steven R YtterbergMayo Clinic College of Medicine, Rochester, Minnesota.
Frederick W MillerNational Institute of Environmental Health Sciences, NIH, Bethesda, Maryland.
Lisa G RiderNational Institute of Environmental Health Sciences, NIH, Bethesda, Maryland.
International Myositis Classification Criteria Project Consortium, the Euromyositis Register, and the Juvenile Dermatomyositis Cohort Biomarker Study and Repository (UK and Ireland)

Funding

Clinical Support Services for the NIAMS Intramural Research ProgramZIDAR041180 · NIAMS · NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES · PI COLBERT, ROBERT · 2009 to 2025
$119.2M
Environmental/genetic Risk Factors and Pathogenesis of Autoimmune DiseaseZIAES101074 · NIEHS · NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES · PI RIDER, LISA · 2009 to 2025
$34.6M
Clinical Training in RheumatologyZIEAR041176 · NIAMS · NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES · PI COLBERT, ROBERT · 2009 to 2025
$29.8M
Assessment, Therapy and Prevention Of Autoimmune DiseaseZIAES101081 · NIEHS · NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES · PI RIDER, LISA · 2009 to 2025
$17.6M
Arthritis Research UK 18474Intramural NIH HHS Z99 ES999999Intramural NIH HHS ZIA ES101074Medical Research Council MR/N003322/1Medical Research Council MR/P020941/1Versus Arthritis 18474
6 · The paper itself

Abstract

objectiveTo develop and validate new classification criteria for adult and juvenile idiopathic inflammatory myopathies (IIM) and their major subgroups.

methodsCandidate variables were assembled from published criteria and expert opinion using consensus methodology. Data were collected from 47 rheumatology, dermatology, neurology, and pediatric clinics worldwide. Several statistical methods were utilized to derive the classification criteria.

resultsBased on data from 976 IIM patients (74% adults; 26% children) and 624 non-IIM patients with mimicking conditions (82% adults; 18% children), new criteria were derived. Each item is assigned a weighted score. The total score corresponds to a probability of having IIM. Subclassification is performed using a classification tree. A probability cutoff of 55%, corresponding to a score of 5.5 (6.7 with muscle biopsy) "probable IIM," had best sensitivity/specificity (87%/82% without biopsies, 93%/88% with biopsies) and is recommended as a minimum to classify a patient as having IIM. A probability of ≥90%, corresponding to a score of ≥7.5 (≥8.7 with muscle biopsy), corresponds to "definite IIM." A probability of <50%, corresponding to a score of <5.3 (<6.5 with muscle biopsy), rules out IIM, leaving a probability of ≥50-<55% as "possible IIM."

conclusionThe European League Against Rheumatism/American College of Rheumatology (EULAR/ACR) classification criteria for IIM have been endorsed by international rheumatology, dermatology, neurology, and pediatric groups. They employ easily accessible and operationally defined elements, and have been partially validated. They allow classification of "definite," "probable," and "possible" IIM, in addition to the major subgroups of IIM, including juvenile IIM. They generally perform better than existing criteria.

Indexed as

Practice Guidelines as TopicAdolescentAdultBiopsyChildConsensusEuropeFemaleHumansMaleMiddle AgedMuscle, SkeletalMyositisRheumatologySensitivity and SpecificitySocieties, Medical

Identifiers

PMID29106061
PMCPMC5846474

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.